https://www.onclive.com/view/jak-inhibitor-based-combos-and-mutation-specific-regimens-comprise-the-future-of-myelofibrosis-management
It won't be long now till the scientific community to our advertising for us, should be a hell of a ride.
Here's a recent interview with Claire Harrison, MD, FRCP, FRCPath. She was the one who accompanied Gary in the recent interim data webinar at ASH 2024.
- Forums
- ASX - By Stock
- Ann: Presentation: Phase 2 study of SNT-5505 in myelofibrosis
SNT
syntara limited
Add to My Watchlist
4.08%
!
4.7¢

https://www.onclive.com/view/jak-inhibitor-based-combos-and-mutat...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
4.7¢ |
Change
-0.002(4.08%) |
Mkt cap ! $76.37M |
Open | High | Low | Value | Volume |
4.9¢ | 5.0¢ | 4.6¢ | $389.3K | 8.169M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 361856 | 4.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.7¢ | 34348 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 361856 | 0.046 |
10 | 877058 | 0.045 |
2 | 322700 | 0.044 |
2 | 120000 | 0.043 |
1 | 500000 | 0.042 |
Price($) | Vol. | No. |
---|---|---|
0.047 | 34348 | 2 |
0.048 | 798731 | 2 |
0.049 | 592919 | 2 |
0.050 | 1192786 | 4 |
0.051 | 350000 | 1 |
Last trade - 16.13pm 23/06/2025 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |